135 related articles for article (PubMed ID: 8061884)
21. Cell viability and the (2',5')oligo(A)-RNase L pathway in human colon carcinoma cells treated with human interferons and double-stranded RNA.
Chapekar MS; Glazer RI
Prog Clin Biol Res; 1985; 202():377-84. PubMed ID: 2421317
[No Abstract] [Full Text] [Related]
22. A novel mechanism of RNase L inhibition: Theiler's virus L* protein prevents 2-5A from binding to RNase L.
Drappier M; Jha BK; Stone S; Elliott R; Zhang R; Vertommen D; Weiss SR; Silverman RH; Michiels T
PLoS Pathog; 2018 Apr; 14(4):e1006989. PubMed ID: 29652922
[TBL] [Abstract][Full Text] [Related]
23. 2'-phosphodiesterase and 2',5'-oligoadenylate synthetase activities in the lowest metazoans, sponge [porifera].
Saby E; Poulsen JB; Justesen J; Kelve M; Uriz MJ
Biochimie; 2009; 91(11-12):1531-4. PubMed ID: 19665065
[TBL] [Abstract][Full Text] [Related]
24. The 100-kDa 2',5'-oligoadenylate synthetase catalyzing preferentially the synthesis of dimeric pppA2'p5'A molecules is composed of three homologous domains.
Rebouillat D; Hovnanian A; Marié I; Hovanessian AG
J Biol Chem; 1999 Jan; 274(3):1557-65. PubMed ID: 9880533
[TBL] [Abstract][Full Text] [Related]
25. Comparative studies on (2'-5')oligoadenylate-related enzyme systems and the antiviral effect of interferon in two mouse cell lines which differ in (2'-5')oligoadenylate sensitivity of their protein synthesizing system.
Taira H; Yamamoto F; Furusawa M; Sawai H; Kawakita M
J Interferon Res; 1985; 5(4):583-96. PubMed ID: 2418128
[TBL] [Abstract][Full Text] [Related]
26. 2- and 8-azido photoaffinity probes. 1. Enzymatic synthesis, characterization, and biological properties of 2- and 8-azido photoprobes of 2-5A and photolabeling of 2-5A binding proteins.
Suhadolnik RJ; Karikó K; Sobol RW; Li SW; Reichenbach NL; Haley BE
Biochemistry; 1988 Nov; 27(24):8840-6. PubMed ID: 3242613
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of DNA topoisomerase I activity by 2',5'-oligoadenylates and mismatched double-stranded RNA in uninfected and HIV-1-infected H9 cells.
Schröder HC; Kelve M; Schäcke H; Pfleiderer W; Charubala R; Suhadolnik RJ; Müller WE
Chem Biol Interact; 1994 Feb; 90(2):169-83. PubMed ID: 8156606
[TBL] [Abstract][Full Text] [Related]
28. Enzyme assays for synthesis and degradation of 2-5As and other 2'-5' oligonucleotides.
Poulsen JB; Kjær KH; Justesen J; Martensen PM
BMC Biochem; 2015 Jun; 16():15. PubMed ID: 26113370
[TBL] [Abstract][Full Text] [Related]
29. Intracellular metabolism of the interferon mediator, 2-5A, using permeabilized cells.
Luxembourg A
Biochim Biophys Acta; 1988 Nov; 951(1):175-81. PubMed ID: 3191130
[TBL] [Abstract][Full Text] [Related]
30. The quest for an efficacious antiviral for respiratory syncytial virus.
Torrence PF; Powell LD
Antivir Chem Chemother; 2002 Nov; 13(6):325-44. PubMed ID: 12718405
[TBL] [Abstract][Full Text] [Related]
31. Homologous 2',5'-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity.
Zhang R; Jha BK; Ogden KM; Dong B; Zhao L; Elliott R; Patton JT; Silverman RH; Weiss SR
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):13114-9. PubMed ID: 23878220
[TBL] [Abstract][Full Text] [Related]
32. The interferon induced 2-5A system in neuroblastoma.
Bruchelt G; Schilbach K; Handgretinger R; Schilling F; Pollwein P; Schwab M; Jacobsen H; Niethammer D; Treuner J
Prog Clin Biol Res; 1991; 366():425-31. PubMed ID: 2068156
[No Abstract] [Full Text] [Related]
33. [RNase L, a crucial mediator of innate immunity and other cell functions].
Bisbal C; Salehzada T
Med Sci (Paris); 2008 Oct; 24(10):859-64. PubMed ID: 18950583
[TBL] [Abstract][Full Text] [Related]
34. Studies on interferon-sensitive cells derived from the interferon-resistant NIH 3T3 clone 1 line.
Mittnacht S; Jacobsen H
Prog Clin Biol Res; 1985; 202():237-45. PubMed ID: 2421304
[TBL] [Abstract][Full Text] [Related]
35. RNase L plays a role in the antiviral response to West Nile virus.
Scherbik SV; Paranjape JM; Stockman BM; Silverman RH; Brinton MA
J Virol; 2006 Mar; 80(6):2987-99. PubMed ID: 16501108
[TBL] [Abstract][Full Text] [Related]
36. Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication.
Díaz-Guerra M; Rivas C; Esteban M
Virology; 1997 Jan; 227(1):220-8. PubMed ID: 9007077
[TBL] [Abstract][Full Text] [Related]
37. The 2-5A/RNase L pathway and inhibition by RNase L inhibitor (RLI).
Bisbal C; Salehzada T; Silhol M; Martinand C; Le Roy F; Lebleu B
Methods Mol Biol; 2001; 160():183-98. PubMed ID: 11265282
[No Abstract] [Full Text] [Related]
38. Analysis of the (2'-5') oligoadenylate system by characterization of cells deficient in their response to interferon.
Panet A; Arad G; Rappoport S; Hochman Y
Prog Clin Biol Res; 1985; 202():345-50. PubMed ID: 2421313
[No Abstract] [Full Text] [Related]
39. The interaction of recombinant HuIFN-gamma 1 and recombinant HuIFN-alpha 2 on the 2-5A system in two distinct cell types.
Fish EN; Banerjee K
Prog Clin Biol Res; 1985; 202():385-90. PubMed ID: 3008171
[No Abstract] [Full Text] [Related]
40. RNA drug therapy acting via the 2-5A synthetase/RNase L pathway.
Suhadolnik RJ; Reichenbach NL; Hitzges PM; Ablashi DV; Strayer DR; Carter WA
Ann N Y Acad Sci; 1993 Jun; 685():756-7. PubMed ID: 8363281
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
